Skip to content
Crick

Browse / compound / HFE C282Y + H63D compound heterozygous

Default is plain English. Flip to Technical for the original clinical wording.

HFE C282Y + H63D compound heterozygous

compoundhematology
Elevated

One copy of HFE C282Y and one copy of HFE H63D detected (compound heterozygous).

You have one copy of each of the two main HFE iron-overload DNA changes — one C282Y and one H63D.

The C282Y/H63D compound heterozygous state carries a small but real risk of iron overload, particularly in combination with metabolic factors (fatty liver, alcohol use). Most compound heterozygotes never develop clinically significant iron overload, but a periodic iron-studies blood panel is reasonable.

Having one of each carries a small but real risk that your body will store too much iron over time, especially if you also have fatty liver or drink heavily. Most people with this combination never develop a real iron problem, but it's worth checking your iron levels with a blood test from time to time.

3 caveats2 references

What this means

Hereditary hemochromatosis is most commonly caused by two C282Y alleles. The compound C282Y/H63D state — one of each — produces a smaller risk signal. Many compound carriers have elevated ferritin without ever developing clinical disease, while a small fraction develop late-onset iron overload, particularly when other liver stressors are present. This is much more clinically meaningful than either single-allele carrier state alone.

Hereditary hemochromatosis — a condition where your body builds up too much iron — is usually caused by having two copies of the C282Y DNA change. Having one C282Y and one H63D is a milder combination. Many people with this pair have slightly higher iron stores on a blood test without ever getting sick, while a smaller number develop iron overload later in life, particularly if they also have other things stressing the liver. It's a much more meaningful finding than having just one of these changes on its own.

Caveats

  • Compound heterozygosity has lower penetrance than C282Y homozygosity but is not benign.
  • Iron-studies blood work (ferritin, transferrin saturation) gives the real picture.
  • Risk is amplified by alcohol use, fatty liver, and other metabolic stressors.

References